This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Xylocaine Jelly 2% (2017-12-18)

Starting date:
December 18, 2017
Posting date:
December 21, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
Healthcare Professionals, General Public, Hospitals
Identification number:
RA-65506

Affected products

Xylocaine Jelly 2%

Reason

Presence of particulate matter in these lots.

Depth of distribution

Wholesalers, pharmacies, hospitals in BC, AB, NB, QC, NL, SK, ON and MB

Affected products

Xylocaine Jelly 2%

DIN, NPN, DIN-HIM
DIN 00001694
Dosage form

Gel

Strength

20 mg/ML Lidocaine Hydrochloride

Lot or serial number
  • SL5082
  • SM5099
  • SI5048
Companies
Recalling Firm
Aspen Pharmacare Canada
111 Queen St E, St 450
Toronto
Ontario
CANADA
Marketing Authorization Holder
Aspen Pharmacare Canada
111 Queen St E, St 450
Toronto
Ontario
CANADA